Dilip Shanghvi
-
Taro in merger agreement with Sun Pharma
Post completion of the merger, the combined entity will firmly move forward, leveraging its global strengths and capabilities to better…
Read More » -
Sun Pharma registers Rs 20,470 M net profit in Q2FY22
The company posts EBITDA at Rs 25,608 million Sun Pharmaceutical Industries has reported financials for the second quarter ending September…
Read More » -
Sun Pharma registers posts adjusted net profit at Rs 19,792 million in Q1
In Q1, the gross sales was at Rs 96,694 million up 29% YoY Sun Pharmaceutical Industries has reported the financials…
Read More » -
SPARC to raise Rs 1,200 cr
Issue warrants to promoter Dilip Shanghvi, others Sun Pharma Advanced Research Company (SPARC) plans to raise to Rs 1,200 crore…
Read More »